TITLE

NAFE's TOP 50 COMPANIES FOR EXECUTIVE WOMEN

AUTHOR(S)
SPENCE, BETTY
PUB. DATE
March 2009
SOURCE
NAFE Magazine;Spring2009, Vol. 32 Issue 1, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article features the top 50 companies for executive women for 2009, chosen by the National Association for Female Executives and Entrepreneurs (NAFE). These companies specialize in information technology (IT), healthcare, financial services, and retail. The top 50 companies for executive women include Xerox, Hewlett-Packard, DuPont, IBM, Cisco Systems, Texas Instruments, Bristol-Myers Squibb, Astrazeneca, Johnson & Johnson, and WellPoint.
ACCESSION #
57578029

 

Related Articles

  • January News Briefs.  // Bio-IT World;Jan/Feb2012, Vol. 11 Issue 1, Special section p1 

    This section offers news briefs on bioinformation. Elsevier, a Dutch publishing company, has acquired Ariadne Genomics, a software provider of pathway analysis tools and semantic technologies for life science researchers. IBM, Bristol-Myers Squibb, DuPont and Pfizer will provide a database of...

  • BMS Snags DuPont Pharma unit for $7.8 Bn.  // Chemical Market Reporter;6/11/2001, Vol. 259 Issue 24, p2 

    Reports on the acquisition of DuPont's pharmaceutical unit by Bristol-Myers Squibb Co. (BMS). Advantage of the acquisition to BMS; Overview of anti-HIV/AIDS drugs manufactured by DuPont; Drugs from DuPont and BMS facing generic competition; Speculation on the value of the acquisition.

  • Bristol-Myers Squibb Buys DuPont's Drugs Unit. Walsh, Kerri // Chemical Week;6/13/2001, Vol. 163 Issue 23, p11 

    Deals with the acquisition of DuPont's pharmaceuticals business by Bristol-Myers Squibb (BMS). Value of the deal; Sales posted by DuPont in 2000; Savings expected by BMS from the transaction; Significance of the deal to DuPont.

  • Carace.  // Royal Society of Medicine: Medicines;2002, p137 

    This article presents information on the drug Carace, manufactured by DuPont and Bristol-Myers Squibb). This drug is a proprietary, prescription-only preparation of the angiotensin converting enzyme inhibitor lisinopril. It can be used as an antihypertensive and in heart failure treatment. It is...

  • Carace Plus.  // Royal Society of Medicine: Medicines;2002, p137 

    This article presents information on the drug Carace Plus, manufactured by DuPont and Bristol-Myers Squibb. This drug is a proprietary, prescription-only compound preparation of the angiotensin converting enzyme inhibitor lisinopril and the diuretic hydrochlorothiazide. It can be used as an...

  • Strong Dollar Weakens Views. Investor's Business Daily // Investors Business Daily;1/28/2015, pA01 

    3 Big caps with overseas exposure eased guidance. Procter &

  • DUPONT EXEC SAYS PROFIT RECOVERY MAY TAKE THREE YEARS.  // Chemical Week;10/12/2009, Vol. 171 Issue 25, p4 

    The article presents the opinion of DuPont executive vice president Mark Vergnano on the company's profit . Vergnano says it will take two and one-half to three years for the firm to return to 2008 profit levels. A net income of 2 billion U.S. dollars have been posted by the company in 2008 and...

  • NEW CAMPAIGNS.  // Advertising Age;8/22/1994, Vol. 65 Issue 35, p39 

    Presents updates on advertising campaigns of companies and organizations in the U.S. as of August 22, 1994. Details of a global campaign for DuPont's Lycra brand; Value of Owens-Corning's advertising campaign in September 1994; Information on the patient advertising campaign of Bristol-Myers...

  • Delivering the goods. Tirschwell, Peter // JoC Week;9/4/2001, Vol. 2 Issue 35, p4 

    Profiles E.I. du Pont de Nemours & Co. transport executive Inka Omholt, who is responsible for purchasing all international ocean, air and third-party logistics services for the chemicals and plastics firm. DuPont executives who have been leaders in the logistics field; Omholt's concern about...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics